Free Trial

UnitedHealth Group Incorporated $UNH Stock Holdings Cut by Gries Financial LLC

UnitedHealth Group logo with Medical background

Key Points

  • Gries Financial LLC significantly reduced its holdings in UnitedHealth Group by 67.7%, now owning only 1,600 shares worth $499,000.
  • Analysts have mixed ratings on UnitedHealth Group, with a consensus rating of "Moderate Buy" and an average target price of $358.95.
  • UnitedHealth Group's latest quarterly earnings report showed EPS of $4.08, missing estimates, while also announcing a quarterly dividend of $2.21 per share.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Gries Financial LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 67.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,600 shares of the healthcare conglomerate's stock after selling 3,356 shares during the quarter. Gries Financial LLC's holdings in UnitedHealth Group were worth $499,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Bayforest Capital Ltd increased its stake in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. Copia Wealth Management acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $42,000. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC boosted its stake in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after buying an additional 37 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Truist Financial increased their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a report on Tuesday, September 9th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $358.95.

View Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Up 1.9%

NYSE:UNH opened at $347.89 on Wednesday. The company has a market cap of $315.07 billion, a PE ratio of 15.07, a P/E/G ratio of 2.23 and a beta of 0.44. The firm's 50 day simple moving average is $297.61 and its 200 day simple moving average is $362.39. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 earnings per share. The business's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI vs. Wall Street: 5 Names It Loves Right Now
3 Growth Stocks to Buy Now… and 3 to Dump Fast
These Sectors Are On Fire: Breaking Down the Market’s Biggest Gainers

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines